On Demand Pharmaceuticals Opens State-of-the-Art Manufacturing Facility in Maryland
Agile biomanufacturing technology incubated by DARPA reaches commercial facility milestone On Demand Pharmaceuticals, Inc. (ODP) announced on Feb. 15 the ...
Tag: Supply Chain
U.S. Delivers Additional Vaccines and Freezer Trucks to Bangladesh for COVID Vaccination Efforts
The U.S. Donates Another 10 Million Pfizer Vaccines to Bangladesh; U.S.-Donated Doses Now Exceed 38 Million The U.S. donated an ...
The US National Blood Crisis: Supply at 10-year Low From Pandemic Disruptions
The blood supply in the U.S. is now at its lowest level in over a decade. Many of the nation’s ...
Scientists Show Plasma Technology Can Safely Clean Disposable PPE for Reuse
A new study from the University of Southampton has demonstrated a new method to safely clean and reuse facemask respirators ...
Dial-a-Threat Rapid Assay Generation Program Could Bypass Reliance on Cold-Chain Supply
The DaT Program aims to develop a highly adaptive, all-encompassing biothreat detection modality that minimizes reliance on supply chain constrictions. ...
New Manufacturing Plant Gives Canada Domestic Production Capability for N95-Type Mask Filters
Medicom to open new plant to produce critical meltblown polypropylene filter raw material for masks. The company will also establish ...
DARPA Awards Nucleic Acids On-Demand (NOW) Contract to GE Research and Collaborators
The Defense Advanced Research Projects Agency (DARPA) has awarded project funding worth up to $41 million to GE Research and a ...
Reimagining US Public Health with Robust Application of Systems Engineering
Of the many things that COVID-19 has made abundantly clear to us, surely one of them is a newfound realization ...
How COVID-19 Vaccines Will Get From the Factory to Your Community
The two major U.S. developers of the early COVID-19 vaccines are Pfizer/BioNTech and Moderna. They both developed mRNA vaccines, a ...
Oxford-AstraZeneca COVID-19 Vaccine: Cheaper and Doesn’t Require Supercold Storage Quagmire
The biopharmaceutical company AstraZeneca has released data on what is now the third promising vaccine candidate against COVID-19 – and ...
U.S. Invests in Pandemic Vaccine Manufacturing Capacity with $31M Contract to Cytiva
The U.S. Department of Health and Human Services and Department of Defense this week announced an agreement with Cytiva to ...
Australia Will Have Its Own Centre for Disease Control, Labor Party Vows
A Labor government would set up an Australian Centre for Disease Control to strengthen the country’s preparedness for future pandemics ...
Harvard Wyss Institute Licenses Diagnostic Technologies to Agile Biodetection
The Wyss Institute for Biologically Inspired Engineering at Harvard University announced today that its nasopharyngeal swab and genomic toehold switch ...
How Pharma is Changing to Produce a Pandemic Vaccine in Rapid Time
To bring COVID-19 under control a vaccine needs to be available to every nation, rich and poor – and it ...
The Challenges of Vaccine Cold-Chain Distribution Must Be Met to End the Pandemic
Just like a fresh piece of fish, vaccines are highly perishable products and must be kept at very cold, specific ...
Pandemic Testing Capacity: 3D Printed Nasal Swabs Shown Comparable to Flocked Swabs
A multisite clinical trial led by the University of South Florida Health (USF Health) Morsani College of Medicine and its primary hospital ...
The Challenge of Vaccine Cold Chain Logistics: How a Chemical ‘Casing’ Could Save Lives
Amid unpredictable outbreaks, and fears of a second wave, the hunt is on for a vaccine against COVID-19. The reason ...
UCLA Study Backs Decontamination of Single-Use N95 Respirators to Mitigate Shortages
N95 respirators, which are widely worn by health care workers treating patients with COVID-19 and are designed to be used ...
Vaccine Approval Is Just The Beginning – Huge Production Challenges Await
The race for a SARS-CoV-2 vaccine is well underway. It’s tempting to assume that once the first vaccine is approved ...
As Long Waits for Results Render COVID Tests ‘Useless,’ States Seek Workarounds
States frustrated by private laboratories’ increasingly long turnarounds for COVID-19 test results are scrambling to find ways to salvage their ...
